On the other hand, a potential therapeutic target for the treatment of breast cancer patients is WZ35, an analog of CUR, which suppresses tumor cell development via the ROS-YAP-JNK signaling pathway [37]. This evidence concerns the gene MAPK8 and breast carcinoma.